Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1992-09-04
1996-07-30
Allen, Marianne P.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241731, 4241921, 435 691, 435 693, 435 697, 4352523, 4353201, 514 12, 530350, 5303871, A61K 39395, A61K 3817
Patent
active
055409261
ABSTRACT:
The present invention relates to soluble ligands for the B-cell antigen, CD40, and, in particular, to human gp39 protein and soluble ligands derived therefrom which may be used in methods of promoting B-cell proliferation.
REFERENCES:
R. J. Armitage et al. Nature 357:80-82 May 7, 1992.
Lauzan, G. J. et al. Molec. Immunol. 25(9):829-41 1988.
Lederman et al., "Identification of a Novel Surface Protein on Activated CD4+T Cells That Induces Contact-Dependent B Cell Differentiation (Help)", J Exp Med 175:1091-1101 (1992).
Noelle and Snow, "T Helper Cells", Current Opinion in Immunology 4:333-337 (1992).
Noelle et al., "A 39-kDa Protein on Activated Helper T Cells Binds CD40 and Transduces the Signal for Cognate Activation of B Cells", Proc. Natl. Acad. Sci. USA 89:6550-6554 (1992).
Aruffo Alejandro
Hollenbaugh Diane
Ledbetter Jeffrey A.
Allen Marianne P.
Bristol--Myers Squibb Company
Spector L.
LandOfFree
Soluble and its use in B cell stimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble and its use in B cell stimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble and its use in B cell stimulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1656490